Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06297655
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-07
First Post:
2024-03-01
Brief Title:
A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co Ltd
Organization:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-04
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-01
First Submit QC Date:
March 1 2024
Study First Post Date:
2024-03-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-01
Last Update Post Date:
2024-03-07
Last Update Post Date Type:
ACTUAL